Preprint tracker

Most active topics

Preprints in the window that matched each object's literature query. Counts overlap: one preprint can match a target and its drug.

Now published

Journal articles from the last 18 months that Europe PMC links back to a preprint on one of these topics. The journal version is the one to cite; the preprint shows how the claim started.

1. A Micropeptide Component of the OGDH Complex Modulates ATP Production in the TCA Cycle.published
   2026-10-18· Yin X et al.preprint versionIobenguane I-131
2. Lipid Extract from Ulva ohnoi Algae: Chemical Characterization, Antibacterial Potential, and Cytotoxicity in the Search for New Agents Against MDR Infections.published
   2026-10-17· Jara MC et al.preprint versionIobenguane I-131
3. Multimodal imaging features of nuclear protein in testis carcinoma of the submandibular gland: a case report.published
   2026-10-16· Shi Y et al.preprint versionPETPET/CT
4. Latent HIV Infection of BBB Pericytes Enhances Gap Junction-mediated Crosstalk with Endothelial Cells.published
   2026-10-16· Schmidlin S et al.preprint versionIobenguane I-131
5. Role of PANoptosis in cancer: molecular mechanisms and therapeutic insights.published
   2026-10-16· Zhang Y et al.preprint versionIobenguane I-131
6. Associations of Antibodies Against Several Infections With Alzheimer Disease Neuropathology: A Prospective Cohort Study Analysis.published
   2026-10-16· Felici C et al.preprint versionAmyloid beta plaques
7. Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes anti-tumour immunity in combination with radiotherapy.published
   2026-10-15· Pedersen M et al.preprint versionIobenguane I-131
8. Volumetric discordance between ¹⁸F-FET-PET/MRI and MRI-based radiotherapy target volumes in high-grade glioma: a prospective pilot study (FETSMaRT).published
   2026-10-14· Singnurkar A et al.preprint versionPET/MRIFloretyrosine F-18
9. Stress-induced vtRNA1-1 modulates redox homeostasis and ferroptosis susceptibility in hepatocellular carcinoma cells.published
   2026-10-13· Kong E et al.preprint versionIobenguane I-131
10. Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression.published
    2026-10-13· Kalfakakou D et al.preprint versionIobenguane I-131
11. Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity With High-Density Progenitor Cell Regions Correlating With High-Risk Disease.published
    2026-10-13· Chien F et al.preprint versionIobenguane I-131
12. Interpretable neural networks prioritize cancer driver genes from genome-wide dependency landscapes.published
    2026-10-13· Yin Q et al.preprint versionIobenguane I-131
13. Inhibition of soluble epoxide hydrolase rescues cognitive deficits by preserving neurovascular integrity and attenuating glial and neuropathology in diabetic-related dementia.published
    2026-10-13· Fang X et al.preprint versionIobenguane I-131Technetium-99m exametazimeDLG4
14. JAK-STAT pathway heterogeneity governs immunotherapy response in breast cancer.published
    2026-10-13· Zhou J et al.preprint versionIobenguane I-131
15. Real-world evidence on the management and outcomes of glioblastoma in elderly patients: a monocentric retrospective analysis.published
    2026-10-13· Müller JA et al.preprint versionTemozolomide
16. Weekly hippocampal diffusion changes during partial-brain radiation therapy for high-grade glioma: associations with dose and early memory change.published
    2026-10-13· Haisraely O et al.preprint versionTemozolomide
17. Monocytic resilience during chemoradiotherapy is independently associated with survival in IDH-Wildtype glioblastoma.published
    2026-10-13· Donnini F et al.preprint versionTemozolomide
18. Predictive value of left ventricular <sup>18</sup>F-FDG PET/CT derived parameters and uptake patterns for chemotherapy-induced cardiotoxicity in patients with lymphoma.published
    2026-10-12· Thong MH et al.preprint versionFDG PETPET/CTFludeoxyglucose F-18
19. Research and development of a multi-target HER2 inhibitor (CPD 1) and its mechanism and application in combating HER2-positive breast cancer.published
    2026-10-12· Pan J et al.preprint versionHER2
20. A Multi-Omic Phenobank Reveals Axes of Glioblastoma Growth, Invasion, and Therapeutic Vulnerability.published
    2026-10-12· Krona C et al.preprint versionIobenguane I-131
21. SREBF1 expression is associated with lipid metabolism-related signatures, and transient SREBF1 silencing is accompanied by increased apoptosis in pancreatic cancer cells.published
    2026-10-12· Wu J et al.preprint versionIobenguane I-131
22. Canonical Wnt induction by OTULIN prevents keratinocyte death and skin inflammation.published
    2026-10-09· Lecomte K et al.preprint versionIobenguane I-131
23. Ion Channel Nano-Diagnostics for ER+ Breast Cancer.published
    2026-10-08· Gkikas M et al.preprint versionHER2
24. Novel RNA polymerase I and cyclin-dependent kinase combination therapy for the treatment of aggressive acute myeloid leukemia.published
    2026-10-08· Hein N et al.preprint versionIobenguane I-131
25. Prognosis and Therapies in Non-Clear Cell Renal Cell Carcinomas.published
    2026-10-07· Shrivastava T et al.preprint versionIobenguane I-131
26. Entropy of the resting state cortex in epilepsy.published
    2026-10-06· Kaur K et al.preprint versionAbiraterone acetateDocetaxel
27. Update in the Molecular Pathogenesis of Sebaceous Carcinoma.published
    2026-10-06· Mano F et al.preprint versionIobenguane I-131
28. Multi-task deep learning integrating pretreatment MRI and whole slide images predicts induction chemotherapy response and survival in locally advanced nasopharyngeal carcinoma.published
    2026-10-05· Hou J et al.preprint versionRadiomicsMonte Carlo dosimetry
29. NK2R signaling governs intestinal lipid mobilization and mucosal inflammation.published
    2026-10-05· Perez PA et al.preprint versionIobenguane I-131
30. Dynamic Immune Responsiveness in Breast Cancer: Tumor Microenvironment Plasticity, Therapeutic Timing, and Clinical Translation.published
    2026-10-04· Udden SMN et al.preprint versionIobenguane I-131
31. Novel Insights into the Biochemistry of Citrate and Its Transporters: Relevance to Metabolic Rewiring, Tumor Microenvironment, and Bone Metastasis in Cancer.published
    2026-10-04· Ganapathy V et al.preprint versionIobenguane I-131
32. Stacked Waves and Qualitative Analysis of an Oncolytic Virus-Immune Model.published
    2026-10-03· Mohammadnejad N et al.preprint versionIobenguane I-131
33. Serum albumin is associated with immune-related hypothyroidism and treatment continuity in non-small cell lung cancer.published
    2026-10-03· Takada K et al.preprint versionNorepinephrine transporter
34. ThermoTargetMiner as a proteome integral solubility alteration target database for prospective drugs against lung cancer.published
    2026-10-02· Lyu H et al.preprint versionIobenguane I-131
35. Once yearly cell-based therapy for sustained and dose-tunable delivery of monoclonal antibodies.published
    2026-10-02· Fell C et al.preprint versionPembrolizumab
36. End-to-End PET/CT Interpretation and Quantification with an LLM-Orchestrated AI Agent: A Real-World Pilot Study.published
    2026-10-01· Choi H et al.preprint versionFDG PETPET/CTFludeoxyglucose F-18
37. Spatial Collinearity Constrains Multivariate Molecular-Enriched Network Estimation.published
    2026-10-01· Lawn T et al.preprint versionPET
38. Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells.published
    2026-10-01· Kuo CF et al.preprint versionHER2
39. CRISPR-HAWK: haplotype- and variant-aware guide design toolkit for CRISPR-Cas.published
    2026-10-01· Kumbara A et al.preprint versionIobenguane I-131
40. PKP2 orchestrates OXPHOS expression in cardiomyocytes via a PGC1α-dependent mechanism.published
    2026-10-01· Han SJ et al.preprint versionIobenguane I-131
41. ZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain.published
    2026-10-01· Lewis C et al.preprint versionIobenguane I-131
42. Sex-Specific Neurogenic and Cognitive Responses in a Murine Model of Accelerated Aging.published
    2026-10-01· Gómez-Oliva R et al.preprint versionIobenguane I-131
43. Machine Learning-Based Development of Gadolinium Binding Peptides.published
    2026-10-01· Dayan NA et al.preprint versionNorepinephrine transporter
44. Inhibition of Hexokinase 2 Undermines Cartilage Health and Accelerates Osteoarthritis.published
    2026-10-01· Xu H et al.preprint versionGLUT1 / hexokinase
45. Plasma Proteome-Wide Mendelian Randomization with Multi-Layer Triangulation Identifies Druggable Targets for Uterine Leiomyoma.published
    2026-09-30· Wang X et al.preprint versionPARP
46. Development of a GPCR-binding ligand screening method using real-time interaction analysis on live cells.published
    2026-09-30· Westin H et al.preprint versionRadioactive iodine
47. Pan-Fibrotic Gene Expression Signature in Major Chronic Diseases by Integrative Bulk and Single-Cell Transcriptomic Analyses.published
    2026-09-30· Jaimes-Campos MA et al.preprint versionNorepinephrine transporter
48. LAT condensation gates PLCγ1 activation via bimodal LAT phosphorylation.published
    2026-09-30· Ren H et al.preprint versionMonte Carlo dosimetry
49. Advances in Somatostatin Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives.published
    2026-09-29· Bakr H et al.preprint versionPeptide receptor radionuclide therapyRadioligand therapyPARP
50. Spatiotemporal modeling of GPCR signaling: The role of endosomal dynamics and receptor recycling.published
    2026-09-29· Weckel C et al.preprint versionAbiraterone acetateDocetaxel
51. Loss of PIMREG impairs double-strand break signaling and repair.published
    2026-09-29· de Rizzo Gasparini MV et al.preprint versionTemozolomide
52. Size-dependent plastic exposure disrupts macrophage function and tissue-specific metabolism.published
    2026-09-29· Makdissi N et al.preprint versionGLUT1 / hexokinase
53. Striatal dopamine synthesis in schizophrenia decreases from psychosis to psychotic remission.published
    2026-09-28· Schulz J et al.preprint versionPET
54. Risk-reducing salpingo-oophorectomy in patients with gBRCA-mutated breast cancer.published
    2026-09-28· Amann N et al.preprint versionHER2
55. Primary ALK-positive anaplastic large cell lymphoma of the urinary bladder in a pediatric patient: a case report and review of literature.published
    2026-09-26· Kaur N et al.preprint versionCT
56. Human lung explants as a predictive platform for evaluating the on-target, off-tumor toxicity of T cell bispecifics.published
    2026-09-26· Tschan M et al.preprint versionFolate receptor alphaIobenguane I-131
57. Stem cell morphology defines functional heterogeneity and therapeutic vulnerabilities in glioblastoma.published
    2026-09-26· Barelli C et al.preprint versionTemozolomide
58. Fe<sub>3</sub>O<sub>4</sub>-Au cluster-satellite particles as direct colorimetric reporters in a smartphone-quantified lateral flow immunoassay for prostate-specific antigen.published
    2026-09-25· Marra D et al.preprint versionKLK2
59. Differential methylation at novel putative imprinting control regions on chromosome 20 associated with childhood obesity.published
    2026-09-25· Everly CF et al.preprint versionIobenguane I-131
60. PDLIM2 in lung adenocarcinoma metastasis.published
    2026-09-25· Gao F et al.preprint versionIobenguane I-131
61. Converting lysosomes into photothermal organelles enables nanoparticle-free tumor ablation via intracellular vapor bubbles.published
    2026-09-25· Lu T et al.preprint versionSunitinib
62. Impacts of Morphology and Elasticity on Cancer Cell Deformation in Shear Flows.published
    2026-09-24· Ahmed M et al.preprint versionNorepinephrine transporter
63. The influence of force on the encoding and perception of affective touch.published
    2026-09-23· Faresse S et al.preprint versionAmyloid beta plaques
64. Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia.published
    2026-09-22· Walker JG et al.preprint versionAbiraterone acetateDocetaxel
65. A physiology-based mathematical model of the renin-angiotensin system, bone remodeling, and calcium homeostasis: Effects of estrogen and renin-angiotensin system inhibitors.published
    2026-09-22· Stadt MM et al.preprint versionBone mineral
66. Chemotherapy-Free Polatuzumab Vedotin and Rituximab (Pola-R) for Frail, Older Patients with Relapsed DLBCL: A Case for Geriatric Assessment and Shared Decision-Making.published
    2026-09-21· Horaguchi R et al.preprint versionRituximab
67. Systemic Inflammatory Response During Coronary Artery Bypass Grafting with Cardiopulmonary Bypass: Cellular and Molecular Mechanisms.published
    2026-09-21· Lazović DM et al.preprint versionNorepinephrine transporter
68. Bone Aging and Glycative Stress: Convergent and Divergent Mechanisms Driving Skeletal Deterioration.published
    2026-09-20· Peñarrubia S et al.preprint versionBone mineral
69. Neuregulin-1 as a Context-Dependent Regulator of Neuroinflammation and Neural Repair: Mechanisms, Disease Relevance, and Therapeutic Challenges.published
    2026-09-19· Ford GD et al.preprint versionHER2
70. Orthodontic Root Resorption in Spontaneously Hypertensive Rats: Modulation by β2-Adrenergic Receptor Blockade.published
    2026-09-18· Yoshida T et al.preprint versionCT
71. The Transcaval AngioVac Aspiration of a Left Subclavian Artery Intimal Sarcoma Masquerading as Arterial Thrombosis: A Case Report.published
    2026-09-18· Matetic A et al.preprint versionCT
72. CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer.published
    2026-09-18· Muneer A et al.preprint versionRadiomics
73. γδ T cells modulate anti-tumor immunity in small cell lung cancer.published
    2026-09-18· Ng J et al.preprint versionDLL3
74. Sex and age at exposure influence <sup>131</sup>I biodistribution and dosimetry in Sprague-Dawley rats.published
    2026-09-18· Schroff A et al.preprint versionNIS
75. Beyond the T-Score: A Narrative Clinical Review of Adult Endocrine Osteoporosis Care.published
    2026-09-18· Georgescu LM et al.preprint versionBone mineral
76. Risk of desmoid tumor based on APC pathogenic variant location and surgical history in familial adenomatous polyposis: a U.S. community cohort study.published
    2026-09-17· Thomas PI et al.preprint versionFAP
77. A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma.published
    2026-09-17· Kilim O et al.preprint versionIobenguane I-131
78. Human Neuronal Modeling of DLG4-Related Synaptopathy Reveals Network Dysfunction and Partial Rescue by Omega-3 Fatty Acid Docosahexaenoic Acid (DHA).published
    2026-09-17· Medina G et al.preprint versionDLG4
79. Assessing bioactivity and biointegration of engineered salivary tissue constructs in a preclinical unilateral fractionated irradiated rat model.published
    2026-09-16· Pernick KP et al.preprint versionCT
80. Contemporary therapy for small node-negative triple-negative breast cancer: a retrospective cohort study.published
    2026-09-16· Lee B et al.preprint versionPembrolizumab

Latest preprints, all topics

1. Longitudinal intratumoral and peritumoral MRI radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma: a retrospective two-center studypreprint
   2026-10-20· Research Square· Lou S et al.RadiomicsNorepinephrine transporter
2. Case Report: Primary hyperparathyroidism with intrathyroidal adenoma in a patient with systemic lupus erythematosus and antiphospholipid syndrome: The first case reportpreprint
   2026-10-20· F1000Res· Baya W et al.SPECT & bone scanSPECT/CT
3. Nationwide HER2 Testing, Prospective Trastuzumab-Based Therapy, and Deep Visual Proteomics in Esophageal Squamous Cell Carcinomapreprint
   2026-10-20· medRxiv· Egebjerg K et al.B7-H3HER2
4. RARRES2 promotes glycolytic reprogramming and malignant phenotypes in clear cell renal cell carcinomapreprint
   2026-10-20· Research Square· Chen L et al.CXCR4GLUT1 / hexokinase
5. Resistance of breast cancer stem cells to TROP2-targeted CAR-T therapy via the NF-κB signaling pathwaypreprint
   2026-10-20· Research Square· Wang H et al.TROP2
6. A Toolkit for Health-economic Analysis with Language-Agnostic Simulation and Sensitivity Analysis (THALASSA)preprint
   2026-10-20· medRxiv· Gomez-Guillen D et al.Abiraterone acetateDocetaxel
7. GLP1R agonists and vorasidenib converge on peroxynitrite-mediated cytotoxicity in mutant IDH gliomapreprint
   2026-10-20· bioRxiv· Taglang C et al.Iobenguane I-131
8. Recombinant SIRT1 expression and SIRT1 METTL3 interaction analysis with computational identification of phytochemical SIRT1 activators and inhibitorspreprint
   2026-10-20· bioRxiv· Hasan MKE et al.Iobenguane I-131
9. Integrating Genetic Domestication and Model-Guided Kill-Switch Engineering in a Non-Model Bacterial Therapeuticpreprint
   2026-10-20· bioRxiv· Jeong Y et al.Iobenguane I-131
10. Antigen recognition licenses therapeutic CD8+ T cells to organize a multicellular myeloid interaction network in the tumor microenvironmentpreprint
    2026-10-20· bioRxiv· Pherez-Farah A et al.Iobenguane I-131
11. NHE1 sustains leukemia-propagating capacity and mitochondrial fitness in T-cell acute lymphoblastic leukemiapreprint
    2026-10-20· bioRxiv· Al-Hamaly MA et al.Iobenguane I-131
12. Functional heterogeneity, tumor vascularization, and the nonlinear dynamics of metastatic cancer treated by oncolytic viral therapypreprint
    2026-10-20· bioRxiv· Evans TP et al.Iobenguane I-131
13. HaloPROTAC-mediated degradation reveals SOX10-dependent gene expression changes in melanoma cellspreprint
    2026-10-20· bioRxiv· Purvis AL et al.Iobenguane I-131
14. A First-in-Class LZK Inhibitor Suppresses Tumor Growth and Potentiates EGFR and PI3K Pathway Blockade in Head and Neck and Esophageal Cancerspreprint
    2026-10-20· bioRxiv· Katerji M et al.Iobenguane I-131
15. Dissecting KEAP1-NRF2 interactions: Structural and functional impact of cancer-associated KEAP1 mutantspreprint
    2026-10-20· bioRxiv· Wang Q et al.Iobenguane I-131
16. MiR-214-3p Confers Ferroptosis Resistance in Gastric Cancer by Targeting the SOCS2/SLC7A11 Axispreprint
    2026-10-20· Research Square· Bi F et al.Iobenguane I-131
17. ASCC1 Promotes Malignant Progression of Pancreatic Cancer by Regulating the NF-κB Signaling Pathwaypreprint
    2026-10-20· Research Square· Wang N et al.Iobenguane I-131
18. Cross-Omics Identification of Core Epithelial Genes Associated with Folate Metabolism in Cervical Cancer and Prediction of an IL1RN/VEGFA Diagnostic Model and Candidate Drugspreprint
    2026-10-20· Research Square· Yan Z et al.Iobenguane I-131
19. Within-host HPV–immune dynamics with epithelial turnover and downstream cervical disease burden: invasion, Hopf bifurcation, and intervention modellingpreprint
    2026-10-20· Research Square· Aldawsari K et al.Iobenguane I-131
20. High-Dose Ifosfamide in Relapsed Advanced Synovial Sarcoma: A Phase II Study of Efficacy and Health-Related Quality of Life outcomes from Indiapreprint
    2026-10-20· Research Square· R VKP et al.Iobenguane I-131
21. Exploratory Associations of Systemic Inflammatory Markers and Prostate Volume with Predominant Gleason Pattern in Gleason Score 7 Prostate Cancerpreprint
    2026-10-20· Research Square· Guo F et al.Iobenguane I-131
22. Sacubitril/Valsartan for Breast Cancer Therapy-Related Cardiac Dysfunction: An Integrated Meta-Analysis and Bioinformatics Studypreprint
    2026-10-20· Research Square· Zhong R et al.Iobenguane I-131
23. A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphomapreprint
    2026-10-20· Research Square· Pattabiraman N et al.Iobenguane I-131GLUT1 / hexokinase
24. Platelet Membrane–Camouflaged PB-MnO₂ Nanobiomimetic for Enhanced Photothermal Tumor Ablationpreprint
    2026-10-20· Research Square· Kiakalaiy AB et al.Iobenguane I-131
25. Lineage plasticity and tumor microenvironment transcriptional features define a novel aggressive state in pediatric rhabdomyosarcomapreprint
    2026-10-20· Research Square· Jachetti E et al.Iobenguane I-131
26. Novel CDDO-Derived Triterpenoids Modulate Cell Proliferation and Oxidative Stress Signaling in Endometrial Cancer Ishikawa Cellspreprint
    2026-10-20· Preprints.org· Lee K et al.Iobenguane I-131
27. Sex- and Cancer-Related Differences in Immune-Related Adverse Events of Pembrolizumab Monotherapy: A Real-World Pharmacovigilance Analysis from EudraVigilancepreprint
    2026-10-20· Preprints.org· Ciappina G et al.Pembrolizumab
28. Targeting poorly differentiated thyroid cancer with bispecific antibodies and CAR T cells from the human anti-TSHR autoantibody repertoirepreprint
    2026-10-20· bioRxiv· Fischer C et al.Radioactive iodine
29. Factors Influencing Recurrence After Initial Transurethral Resection of Bladder Tumor (TURBT) in Stage T2 Bladder Cancer and the Development of a Predictive Modelpreprint
    2026-10-20· Research Square· liu c et al.Norepinephrine transporter
30. Comparative analysis of plasma sample preparation methods for high-throughput mass spectrometry-based proteomics and application to colorectal cancerpreprint
    2026-10-20· Research Square· Liu J et al.Norepinephrine transporter
31. Clinicopathologic Predictors of PSMA-PET Detection, Recurrence Pattern, and Biochemical Outcome Following Salvage Radiotherapy After Radical Prostatectomypreprint
    2026-10-19· medRxiv· Jubril R et al.PSMA PET
32. Functional epigenomic liquid biopsy identifies potential therapeutic vulnerabilities after enfortumab vedotin–pembrolizumab resistance in metastatic urothelial carcinoma (mUC)preprint
    2026-10-19· Research Square· Bellmunt J et al.B7-H3HER2TROP2Iobenguane I-131PembrolizumabHER3
33. STIM1 at the plasma membrane: A novel Molecular regulator of B cell migration.preprint
    2026-10-19· bioRxiv· LE GOUX N et al.CXCR4Iobenguane I-131
34. CROSS-PLATFORM CONCORDANCE ANALYSIS REVEALS ROBUST AND CLINICALLY RELEVANT GENE SIGNATURES IN BREAST CANCERpreprint
    2026-10-19· bioRxiv· Imhanbor JO et al.HER2Iobenguane I-131
35. Preclinical Evaluation of [18F]Itareparib, a brain penetrant PARP1-selective radioligand, in Glioma Rat Model and Nonhuman Primatepreprint
    2026-10-19· bioRxiv· Tan PW et al.PARP
36. Mitophagy is required for cell survival upon ultrasound and microbubble therapeutic exposurepreprint
    2026-10-19· bioRxiv· Cloves E et al.Iobenguane I-131
37. Metabolite-centric Knowledge Graph Unveils Predictive and Mechanistic Insights through Self-supervised Multimodal Learningpreprint
    2026-10-19· bioRxiv· Lu Y et al.Iobenguane I-131
38. Droplet-based organoid screens enable high-throughput identification of cancer vulnerabilitiespreprint
    2026-10-19· bioRxiv· Xia Y et al.Iobenguane I-131
39. Development and pharmacological characterization of a stable HEK293 cell model for the study of human FLT3 signaling and its pharmacological modulationpreprint
    2026-10-19· bioRxiv· Bourki H et al.Iobenguane I-131
40. Improved anti-tumor vaccination activity of necroptotic cells lacking ATG16L1-dependent unconventional autophagypreprint
    2026-10-19· bioRxiv· Bandera-Linero J et al.Iobenguane I-131
41. Preparation, Characterization, and In Vitro Cytotoxic Evaluation of Pyrimidine-Loaded Mg-Ca-Fe Layered Double Hydroxides Against Kasumi-1 Leukemia Cellspreprint
    2026-10-19· Research Square· Moaty SAA et al.Iobenguane I-131
42. Anti-Inflammatory Lipid Nanoparticles Derived from Kaempferol: A Dual- Functional mRNA Delivery Platform for Lung Cancer Therapypreprint
    2026-10-19· Research Square· Li R et al.Iobenguane I-131
43. Adenosquamous carcinoma of the colon with an aberrant MLH1 immunostaining pattern: a diagnostic pitfall in mismatch repair assessmentpreprint
    2026-10-19· Research Square· Betini BG et al.Iobenguane I-131
44. The effect of cachexia-inducing lung tumor-conditioned medium on the therapeutic potential of human mesoangioblastspreprint
    2026-10-19· Research Square· Wanders N et al.Iobenguane I-131
45. High-throughput screening identifies proteasome inhibition as promising strategy for treatment of ALK-mutant neuroblastomapreprint
    2026-10-19· Research Square· Picard D et al.Iobenguane I-131
46. Characterization of IKBIP prognostic values in collaboration with immune infiltrates in gliomapreprint
    2026-10-19· Research Square· Zhao C et al.Iobenguane I-131
47. Integrative transcriptomic and machine learning analyses identify ABCD1 as a diagnostic and prognostic biomarker in cutaneous melanomapreprint
    2026-10-19· Research Square· Zhang H et al.Iobenguane I-131
48. Immunosuppressive Tumour Microenvironment as a Key Factor of Resistance to Therapy with Immune Checkpoint Inhibitors in Hepatocellular Carcinomapreprint
    2026-10-19· Preprints.org· Moiseenko A et al.Iobenguane I-131
49. Untreated controls reveal that pre-treatment prediction of cancer cell fate mostly reflects growth fitnesspreprint
    2026-10-19· Research Square· Noor R et al.Olaparib
50. Immune checkpoint inhibitor adverse events in colorectal cancer: a disproportionality analysis of FAERS with cross-database validation in JADERpreprint
    2026-10-19· Research Square· Yan Y et al.Pembrolizumab
51. Implementation of novel approaches for management and treatment of brain tumourspreprint
    2026-10-19· Authorea Preprints· Ghosn YB.Temozolomide
52. Prediagnosis Smoking and Survival in Lung, Bladder, Kidney, and Head and Neck Cancers: A Population-Based Data Linkage Studypreprint
    2026-10-19· medRxiv· Akpan E et al.Norepinephrine transporter
53. Pyruvate partitioning defines an immunosuppressive metabolic niche in colorectal cancerpreprint
    2026-10-19· bioRxiv· Zheng J et al.GLUT1 / hexokinase
54. Edematous dermatomyositis as a rare cause of isolated bilateral arm swelling in a patient with urothelial carcinoma: case report and literature reviewpreprint
    2026-10-18· Research Square· Pfeifer O et al.CTRituximab
55. Deep learning integrated clinical-radiomics model for prognostic prediction in locally advanced cervical cancer through 18 F-FDG PET/CT and MRI combinationpreprint
    2026-10-18· Research Square· Song J et al.FDG PETPET/CTRadiomicsFludeoxyglucose F-18
56. Interactive Lesion Segmentation in Whole-Body PET/CT and Longitudinal CT: The autoPET/CT-IV Challengepreprint
    2026-10-18· Research Square· Choudja POM et al.PETPET/CT
57. Follicular Dendritic Cell Sarcoma Arising in the Aortopulmonary Window: A Case Report of Complete Resection Using Proximal Pulmonary Artery Controlpreprint
    2026-10-18· Research Square· Yokota N et al.PETSomatostatin receptor 2
58. Association of intratumoral and peritumoral apparent diffusion coefficients with stromal tumor-infiltrating lymphocyte levels in primary triple-negative breast cancer: a retrospective 3-T MRI studypreprint
    2026-10-18· Research Square· Tsukada H et al.PET/CT
59. Imaging biomarkers for early detection, monitoring, and prediction of treatment- related side effects after radiotherapy: A scoping reviewpreprint
    2026-10-18· Research Square· West NA et al.Quantitative imaging biomarkers
60. Single-cell transcriptomics reveals anatomical-site-associated immune-stromal remodeling in abdominopelvic NF2-related schwannomatosispreprint
    2026-10-18· Research Square· Shen Q et al.CXCR4
61. Extratumoral Insulin-Like Growth Factor-1 Promotes Resistance To HER2-Targeted Tyrosine Kinase Inhibitors And Macrophage Polarization Through Redox Signalingpreprint
    2026-10-18· Research Square· Dutta N et al.HER2
62. Long-term outcomes of fixed-duration venetoclax–rituximab in relapsed/refractory chronic lymphocytic leukemia: impact of prior BTK inhibitor exposure and measurable residual disease in a multicenter real-world studypreprint
    2026-10-18· Research Square· Giordano C et al.Rituximab
63. Unintentional Weight Loss Preceding Relapsing-Remitting Multiple Sclerosis: A Case Report and Review of Possible Mechanismspreprint
    2026-10-18· Research Square· Mohammadi HR et al.Rituximab
64. Spatial Mapping of Cytotoxic T Cell Exclusion Associated with Hypoxic PLAUR+ Macrophages in Triple-Negative Breast Cancerpreprint
    2026-10-18· Research Square· Choi S et al.uPAR
65. A Multiplex Protein Microarray Platform for Preclinical Tissue Binding and Cross-Reactivity of Therapeutic Antibodiespreprint
    2026-10-17· bioRxiv· Matsukura S et al.HER2Iobenguane I-131
66. Impact of coronary artery calcification detection on cardiovascular care trajectories in patients undergoing lung cancer screening: a systematic reviewpreprint
    2026-10-16· Research Square· Lee S et al.CT
67. Integrated Multi-Omics Analysis Identifies ATAD5 as a Mediator of Tumor Plasticity and Immunosuppressive Microenvironmental Remodeling in Castration-Resistant Prostate Cancerpreprint
    2026-10-16· Research Square· Li R et al.FAP
68. Same-cell mapping of epigenetic regulatory state to functional proteomic outputpreprint
    2026-10-16· bioRxiv· Wang X et al.HER2
69. NAD⁺/NADH as the Electrochemical Currency and Other Specific Electron Transfer Molecules in Health and Diseasepreprint
    2026-10-16· Preprints.org· Koltai T.PARP
70. MYC targeted de novo binders impair tumor growthpreprint
    2026-10-16· bioRxiv· McNamara-Bordewick NK et al.Iobenguane I-131
71. Targeting <i>TMPRSS2-ERG</i> Fusion-Driven Prostate Cancer using Novel HBS-α-Helicomimicspreprint
    2026-10-16· bioRxiv· Kundu S et al.Iobenguane I-131
72. Genomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clonespreprint
    2026-10-16· bioRxiv· Becker NJ et al.Iobenguane I-131
73. Metabolically encoded cell-surface glycoRNA remodeling enhances antitumor immunitypreprint
    2026-10-16· bioRxiv· Niu B et al.Iobenguane I-131
74. High-throughput affinity profiling of antibodies against soluble and native membrane targets by digital flow cytometrypreprint
    2026-10-16· bioRxiv· Cheng Y et al.Iobenguane I-131
75. Combining an autoactivated cGAS mutant with membrane-tethered IL-12 via mRNA lipid nanoparticles promotes systemic tumor controlpreprint
    2026-10-16· bioRxiv· Zhang A et al.Iobenguane I-131
76. Combined statin probiotic treatment mitigates atherogenic dyslipidemia fueling NAFLD in high-cholesterol-diet fed ratspreprint
    2026-10-16· bioRxiv· Rajkumar A et al.Iobenguane I-131
77. Network-enabled drug repurposing identifies lithium to promote cardiomyocyte proliferationpreprint
    2026-10-16· bioRxiv· Wintruba KL et al.Iobenguane I-131
78. Lipid nanoparticle-mediated RNAi targeting of KRAS mutants sensitises colorectal cancer cells to chemotherapypreprint
    2026-10-16· bioRxiv· Wang Y et al.Iobenguane I-131
79. Dietary serine and glycine restriction delays cancer-associated cachexiapreprint
    2026-10-16· bioRxiv· Papalazarou V et al.Iobenguane I-131
80. ADAR in Ovarian Cancer: Integrating Mendelian Randomization, Transcriptomic Profiling, and Immunohistochemical Validation to Identify ARHGAP25 and SAMHD1 as Potential Targetspreprint
    2026-10-16· Research Square· Li X et al.OlaparibSorafenib
81. Does the Disease-free Survival Benefit of Adding Belzutifan to Adjuvant Pembrolizumab Persist Beyond the Planned Treatment Period? A Reconstructed Individual Patient Data Analysis of Phase 3 Renal Cell Carcinoma Trialspreprint
    2026-10-16· medRxiv· Chang H et al.Pembrolizumab
82. The Optimal Biological Therapy for Conversion in Patients with RAS Wild Type Colorectal Cancer and Unresectable Liver Metastasespreprint
    2026-10-16· Preprints.org· Džunić M et al.NIS
83. Polygenic Risk Scores for Pancreatic Cancer Risk Prediction and Early Detection: A Systematic Evidence Review of Clinical Utilitypreprint
    2026-10-16· Preprints.org· Elsaid MI et al.Norepinephrine transporter
84. Unlocking Auger electron therapy via heavy-ion measurementspreprint
    2026-10-15· Research Square· Heery J et al.Auger-electron therapy
85. Alpha Spatial: Language-guided prediction of single-cell spatial gene expression from histologypreprint
    2026-10-15· bioRxiv· Yang X et al.HER2
86. Correlation of Axillary Nodal with Breast Response Following Neoadjuvant Chemotherapy in Early Breast Cancerpreprint
    2026-10-15· medRxiv· Agrawal A et al.HER2
87. Global signatures of Ribonucleotide Excision Repair deficiency and its therapeutic vulnerabilitiespreprint
    2026-10-15· bioRxiv· Toong PJ et al.Iobenguane I-131
88. Discovery of frameshift-associated TCRs following personalized neoantigen vaccination in a patient with osteosarcomapreprint
    2026-10-15· bioRxiv· Bennett SN et al.Iobenguane I-131
89. Cancer cachexia overrides sex-specific traits in Drosophilapreprint
    2026-10-15· bioRxiv· Rivero A et al.Iobenguane I-131
90. Self-supervised pretraining for dermoscopic lesion segmentation with limited labels: A controlled comparison of initialisation strategiespreprint
    2026-10-15· medRxiv· Hamdan HK et al.Norepinephrine transporter
91. Metformin promotes the expansion of CD8+ central memory T cells by offsetting Pentose phosphate pathwaypreprint
    2026-10-15· Research Square· Hong XF et al.GLUT1 / hexokinase
92. Comparison of Endoscopic Ultrasound, Computed Tomography and Magnetic Resonance Imaging for Preoperative Tumor-Size Assessment in Resected Pancreatic Neoplasmspreprint
    2026-10-14· Research Square· Wu C et al.CT
93. Safety and Efficacy of Dosimetry-Guided 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Advanced GEP-NETs: A Systematic Review and Meta-Analysispreprint
    2026-10-14· Research Square· Dung ATP et al.Lutetium-177 radioligand therapyPeptide receptor radionuclide therapyRadioligand therapyLutetium-177 dotatate
94. Outcomes of PSMA radioligand therapy in lymph node-only metastatic prostate cancer: seven-year results from a single centrepreprint
    2026-10-14· Research Square· Yaxley J et al.PET/CTPSMA PETRadioligand therapyPSMA
95. Free-to-total PSA Ratio Predicts PSMA PET Uptake in Treatment-naive Prostate Cancerpreprint
    2026-10-14· Research Square· zhang z et al.PET/CTPSMA PETPSMAGallium-68 gozetotide
96. PSA Trends and Clinical Outcomes Following Radiotherapy Combined with Androgen Deprivation Therapy for Prostate Cancer: A Single-Centre Retrospective Cohort Study from Saudi Arabiapreprint
    2026-10-14· Research Square· alkhamees M et al.PSMA PETPSMA
97. Development and in vivo characterization of the first peptide-based 99mTc-Nitrido-radiopharmaceuticals for FAP-targeted SPECT imagingpreprint
    2026-10-14· Research Square· Kleynhans J et al.SPECT & bone scanSPECT/CTFAPFAP-2286DOTA chelation
98. Prognostic Analysis of Iodine-avid Residual Metastatic Lymph Nodes in Differentiated Thyroid Cancerpreprint
    2026-10-14· Research Square· Xu R et al.SPECT & bone scanSPECT/CTRadioactive iodine
99. Exploration of potential roles of paraptosis-related prognostic genes in multiple myeloma development and experimental validationpreprint
    2026-10-14· Research Square· chen y et al.B7-H3
100. Early-onset spontaneous murine mammary tumors show increased lymphocyte representation and reduced MHC antigen presentationpreprint
     2026-10-14· bioRxiv· Ray R et al.HER2
101. Spatial Tumour Tissue Distribution Dynamics of a Bicycle Peptide-MMAE Toxin Conjugate Profiled by Targeted Mass Spectrometrypreprint
     2026-10-14· bioRxiv· Ioannidi M et al.Nectin-4
102. Evaluate epidemiologic burden, treatment patterns and treatment outcomes of advanced prostate cancer in Hong Kong using territory-wide electronic medical recordspreprint
     2026-10-14· medRxiv· Jiao Y et al.PARP
103. Predicting resistance to synthetic lethal therapies in cancerpreprint
     2026-10-14· bioRxiv· Yazar M et al.PARP
104. Investigating renal tissue responses to radiopharmaceutical therapy using multiparametric MRI ​preprint
     2026-10-14· Research Square· Liang C et al.PSMA
105. PD-L1 Positivity Rates in Head and Neck Squamous Cell Carcinoma in a UK Reference Centrepreprint
     2026-10-14· Research Square· Templer¹ B et al.Pembrolizumab
106. First Adult Case of Echovirus 21–Associated Poliomyelitis-Like Myelitis Presenting with Flaccid Asymmetric Tetraparesispreprint
     2026-10-14· Research Square· Farhood I et al.Rituximab
107. A Rare Presentation of Acute-Onset BCG-Induced Aortic Aneurysm: A Case Reportpreprint
     2026-10-14· Preprints.org· Parsi S et al.Technetium Tc-99m albumin aggregated
108. LuTuFlow: a deep learning-based pipeline for quantitative characterization of mouse lung tumors in CT imagingpreprint
     2026-10-14· bioRxiv· Liu Y et al.Norepinephrine transporter
109. Limits of marker information transfer in cross-panel cytometry imputationpreprint
     2026-10-14· bioRxiv· Lee J et al.Norepinephrine transporter
110. Machine-Learning Models Using Multidimensional Habitats MRI Features for Assessing Recurrence and Metastasis Risk in Locally Advanced Nasopharyngeal Carcinomapreprint
     2026-10-14· Research Square· Lu Y et al.Norepinephrine transporter
111. Dynamic prognostic evaluation of oral squamous cell carcinoma using net and conditional survival rates: A retrospective cohort studypreprint
     2026-10-14· Research Square· Shinohara K et al.Norepinephrine transporter
112. Tumor-agnostic multimodal cell-free DNA analysis improves detection and enables longitudinal disease monitoring in esophageal adenocarcinomapreprint
     2026-10-14· Research Square· Bartolomucci A et al.Norepinephrine transporter
113. Biologically Inspired Selective Attention for Prostate MRI: A Segmentation-Guided Vision Transformer Framework for Computer-Aided Diagnosispreprint
     2026-10-14· Preprints.org· Iqbal S et al.Norepinephrine transporter
114. Bone Mineral Density and Trabecular Bone Score in Adults With X-Linked Hypophosphatemia and Tumor-Induced Osteomalaciapreprint
     2026-10-14· Research Square· Burnier A et al.Bone mineral
115. MicroRNA192-5p demethylation inhibits glucose metabolism and angiogenesis in non-small cell lung cancer by targeting EREG/PI3K/AKTpreprint
     2026-10-14· Research Square· Li P et al.GLUT1 / hexokinase
116. Does Specific Activity Provide a Clinical Advantage in Lu-177 PSMA Therapy? A Comparison of the Clinical Efficacy, Molecular Response, and Safety Profiles of CA and NCA Lu-177preprint
     2026-10-13· Research Square· Selcuk NA et al.Lutetium-177 radioligand therapyPET/CTPSMA PETRadioligand therapyPSMA
117. MRI Biomarkers for Brain Metastases in Lung Cancer Using Machine Learningpreprint
     2026-10-13· medRxiv· Chadha S et al.Quantitative imaging biomarkers
118. FLASH X-rays preserve neutrophil chromatin to boost antitumor immunitypreprint
     2026-10-13· bioRxiv· Shi X et al.Radio-antibody & radio-ADCNorepinephrine transporter
119. Targeting Cardiac Fibrosis with Chimeric Antigen Receptor Neutrophils Derived from Human Pluripotent Stem Cellspreprint
     2026-10-13· bioRxiv· Jin G et al.FAP
120. Beyond ERBB2 amplification: RNA and proteomic HER2 assessment for pan-tumor treatment stratificationpreprint
     2026-10-13· medRxiv· Egebjerg K et al.HER2
121. Multimodal Machine Learning–Based Clinical and Genomic Prognostic Factors for Progression-Free Survival in Metastatic Breast Cancer Using Phase III MONALEESA Trialspreprint
     2026-10-13· medRxiv· Wang C et al.HER2
122. Successful Trastuzumab Deruxtecan Treatment After AdjuvantTrastuzumab-Induced Heart Failure: A Case Reportpreprint
     2026-10-13· Research Square· Fuchikami H.HER2
123. Pan-cancer remodeling of reactive oxygen species homeostasis: distinct roles of the ROS-generation and antioxidant arms in immune context and outcomepreprint
     2026-10-13· bioRxiv· Xie K et al.Abiraterone acetateDocetaxelNorepinephrine transporter
124. Heart disease detection with trust-based authentication framework in Edge-cloud-IoMT using Adaptive Aggregation Multi-scale Fusion Networkpreprint
     2026-10-13· Research Square· Suryavanshi NS et al.Norepinephrine transporter
125. A three-gene expression score is equivalent to a 25-gene panel as an independent prognostic factor in clear cell renal cell carcinomapreprint
     2026-10-13· Research Square· Lian B et al.Norepinephrine transporter
126. Glyceraldehyde-3-phosphate sensing by SOS1 and RAS sustains a self-reinforcing oncogenic metabolic-signaling circuitpreprint
     2026-10-13· bioRxiv· Xia R et al.GLUT1 / hexokinase
127. Post-engagement CAR release, rather than equilibrium affinity, governs repetitive stromal targeting by CAR-NK cellspreprint
     2026-10-13· Research Square· Jang M et al.Mesothelin
128. When the wild type hits the ceiling: identifiability of mutation–lineage interactions in pharmacogenomic panelspreprint
     2026-10-13· Research Square· Bao J et al.Monte Carlo dosimetry
129. Structural Basis for the Rational Design of UAMC-1110-Based FAP Radiopharmaceuticalspreprint
     2026-10-12· bioRxiv· Zhang C et al.FAP
130. Trastuzumab deruxtecan kills skin and uveal melanoma in vivo by HER2-independent payload releasepreprint
     2026-10-12· bioRxiv· Nilsson LM et al.HER2
131. FORESEE: A prospective feasibility trial of functional precision oncology for metastatic breast cancer patientspreprint
     2026-10-12· medRxiv· Vaklavas C et al.HER2
132. Efficacy of Tumor Treating Fields (TTFields) in triple negative breast cancer cells and synergy with PARP inhibitor talazoparibpreprint
     2026-10-12· bioRxiv· Ghandali M et al.PARP
133. A Harmonized GC–FID Method for Multi-Product Residual Solvent Analysis in Diagnostic and Therapeutic Radiopharmaceuticalspreprint
     2026-10-12· Research Square· Jabari S et al.Fludeoxyglucose F-18
134. Lipid-Lowering Therapy Use and Survival Outcomes in Advanced Renal Cell Carcinoma Treated with Toripalimab Plus Axitinib or Sunitinib: A Post Hoc Analysis of the Phase III RENOTORCH Trialpreprint
     2026-10-12· Research Square· Zhai Y et al.Sunitinib
135. Positive selection and structural disruption of KCNA5 by mutation in colorectal cancerpreprint
     2026-10-12· bioRxiv· Xu B et al.Monte Carlo dosimetry
136. Plasma exosomal miR-29b promotes the progression of endometrial cancer by activating the Wnt/β-catenin signaling pathway via FOLR1-mediated regulation of CTNNB1preprint
     2026-10-11· Research Square· Su J et al.Folate receptor alpha
137. Genome-based benchmarking of 177 different breast cancer polygenic risk scorespreprint
     2026-10-11· Research Square· Eyol E et al.HER2
138. Collapsing Focal Segmental Glomerulosclerosis Progression to ESRD Following Combination Therapy with Pembrolizumab and Enfortumab Vedotin: A Case Reportpreprint
     2026-10-11· Research Square· Hitti G et al.Nectin-4PembrolizumabRituximab
139. Thrombotic Risk of Targeted Therapies in Breast Cancer: A Real-World Cohort Studypreprint
     2026-10-11· Research Square· Boland W et al.PARPEverolimus
140. Six-Weekly Low-Dose Nivolumab Combined with Oral Triple Metronomic Chemotherapy for Advanced Cancers of the Head and Neck: An Open-Label, Prospective, Single-Institution Experience from Eastern Indiapreprint
     2026-10-11· Research Square· Swain SK et al.Pembrolizumab
141. Pannexin Channels at the Interface of Metabolic Perturbation and Purinergic Signalingpreprint
     2026-10-11· Authorea Preprints· Fu H et al.Monte Carlo dosimetry
142. BSC9 a betulin–acetazolamide conjugate enhances radiosensitivity in 2D and 3D HNSCC modelspreprint
     2026-10-10· Research Square· Knobloch-Sperlich D et al.CAIX
143. Dimercaptosuccinic Acid (DMSA) Reduces Renal Uptake of ¹⁷⁷Lu After [¹⁷⁷Lu]Lu-Octreotate Administration in Micepreprint
     2026-10-09· Preprints.org· Ståhl I et al.Lutetium-177 radioligand therapyRadioligand therapy
144. The Uromigos Score in Asian Countries: A Regional Analysis of Expert Treatment Preferences in Genitourinary Oncologypreprint
     2026-10-09· Research Square· Kitamura H et al.Lutetium-177 radioligand therapyRadioligand therapyPSMADurvalumabPembrolizumab
145. Molecular PET Imaging Versus Conventional Imaging for Detection of Mandibular Metastases in Prostate Cancer: A Paired Retrospective Studypreprint
     2026-10-09· Preprints.org· Mahmoud ME et al.PET/CTPSMA PETPSMAGallium-68 gozetotide
146. A spatial AI-based biomarker with independent prognostic value in early low- and intermediate- risk breast cancerpreprint
     2026-10-09· medRxiv· Boissin C et al.HER2
147. NECTIN4 defines a subtype-dependent tumor state coupling enfortumab vedotin targetability to antitumor immunity in bladder cancerpreprint
     2026-10-09· bioRxiv· Nishimura K et al.Nectin-4
148. Targeting ribosome biogenesis sensitizes PARPi-resistant triple-negative breast cancerpreprint
     2026-10-09· bioRxiv· Frederick MI et al.Olaparib
149. A novel HDAC6/HIF-1α dual inhibitor halts malignant progression and reprograms immune microenvironment in triple-negative breast cancerpreprint
     2026-10-09· Research Square· Duan H et al.Sorafenib
150. Lung [ ¹⁸ F]FDG-PET is an early pharmacodynamic biomarker of antiviral efficacy in preclinical influenzapreprint
     2026-10-08· bioRxiv· Luena Victorio CB et al.CTFDG PETPETFludeoxyglucose F-18

Showing the 150 most recent of 658; the per-topic sections below list the rest.

By topic